Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PI3Kγ inhibitors(Phosphatidylinositol 3 kinase gamma inhibitors), PI3Kδ inhibitors(Phosphatidylinositol 3 kinase delta inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cutaneous T-Cell Lymphoma | Preclinical | US | - | |
Peripheral T-Cell Lymphoma | Preclinical | US | - | |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Preclinical | US | - |